SCHEMBL43627

SCHEMBL43627

O=[N+]([O-])c1cccnc1[S]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.56
POLB P06746 1/20 0.55
ALDH1A1 P00352 5/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 3/20 0.46
PAX8 Q06710 1/20 0.46
MAPT P10636 5/20 0.46
KDM4E B2RXH2 2/20 0.46
CTSB P07858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
IDO1 P14902 1/20 0.46
TDO2 P48775 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529342 0.79 PDE10A (0.56) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL6512953 0.78 PDE10A (0.60) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL29940575 0.78 PDE10A (0.60) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL4714866 0.77 PDE10A (0.58) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL244559 0.77 HSP90AA1 (0.59) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL29579675 0.77 PDE10A (0.58) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL294121 0.77 PDE10A (0.58) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL13093318 0.77 PDE10A (0.63) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL23111873 0.76 PDE10A (0.53) PDE10APOLBALDH1A1CYP1A2CYP2C9
SCHEMBL1232447 0.75 PAX8 (0.58) PDE10APOLBALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2181 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939404-B2 Method for producing cyclized peptide having intramolecular S-S bond AJINOMOTO CO., INC. (JP) 2024-03-26 US claimed
US-11779653-B2 Multi-armed polyrotaxane platform for protected nucleic acid delivery THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-10 US claimed
EP-3565573-B1 PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF UNIV CALIFORNIA (US) 2023-08-23 EP claimed
US-11673957-B2 Anti-ROR2 antibodies Eureka Therapeutics, Inc. (US) 2023-06-13 US claimed
US-11555055-B2 Peptide inhibitors of insulin-degrading enzyme THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-01-17 US claimed
EP-3882255-A1 METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND AJINOMOTO CO., INC. (JP) 2021-09-22 EP claimed
US-20210277063-A1 METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND AJINOMOTO CO., INC. (JP) 2021-09-09 US claimed
US-10899791-B2 Method for synthesizing etelcalcetide or salts thereof CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD (TW) 2021-01-26 US claimed
US-20200376139-A1 MULTI-ARMED POLYROTAXANE PLATFORM FOR PROTECTED NUCLEIC ACID DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-12-03 US claimed
US-20200354407-A1 PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-11-12 US claimed
WO-2001013112-A1 MELANOCORTIN METALLOPEPTIDE CONSTRUCTS, COMBINATORIAL LIBRARIES AND APPLICATIONS PALATIN TECHNOLOGIES, INC. (US) 2001-02-22 WO claimed
EP-1042298-A1 POLYCYCLIC ALPHA-AMINO-EPSILON-CAPROLACTAMS AND RELATED COMPOUNDS Elan Pharmaceuticals, Inc. (US) 2000-10-11 EP claimed
WO-2000036136-A1 METALLOPEPTIDE COMBINATORIAL LIBRARIES AND APPLICATIONS PALATIN TECHNOLOGIES, INC. (US) 2000-06-22 WO claimed
EP-0988394-A1 COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF ONCOIMMUNIN, INC. (US) 2000-03-29 EP claimed
US-6037137-A FLUORESCENT COMPOUND FOR SCREENING CLEAVING ACTIVITY AND STRUCTURAL CHANGES OF ENZYMATIC PROTEINS ONCOIMMUNIN, INC. (US) 2000-03-14 US claimed
WO-1999032453-A1 POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 1999-07-01 WO claimed
WO-1998037226-A1 COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES AND METHODS OF USE THEREOF ONCOIMMUNIN, INC. (US) 1998-08-27 WO claimed
EP-0694041-A1 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-31 EP claimed
WO-1994022911-A2 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-13 WO claimed
EP-0152255-A2 New renin-inhibitory peptides and their use SANKYO COMPANY LIMITED (JP) 1985-08-21 EP claimed